Schuepbach-Mallepell Sonia, Das Dolon, Willen Laure, Vigolo Michele, Tardivel Aubry, Lebon Luc, Kowalczyk-Quintas Christine, Nys Josquin, Smulski Cristian, Zheng Timothy S, Maskos Klaus, Lammens Alfred, Jiang Xuliang, Hess Henry, Tan Seng-Lai, Schneider Pascal
From the Department of Biochemistry, University of Lausanne, CH-1066 Epalinges, Switzerland.
Biogen, Cambridge, Massachusetts 02142.
J Biol Chem. 2015 Jun 26;290(26):16330-42. doi: 10.1074/jbc.M115.661405. Epub 2015 May 7.
The closely related TNF family ligands B cell activation factor (BAFF) and a proliferation-inducing ligand (APRIL) serve in the generation and maintenance of mature B-lymphocytes. Both BAFF and APRIL assemble as homotrimers that bind and activate several receptors that they partially share. However, heteromers of BAFF and APRIL that occur in patients with autoimmune diseases are incompletely characterized. The N and C termini of adjacent BAFF or APRIL monomers are spatially close and can be linked to create single-chain homo- or hetero-ligands of defined stoichiometry. Similar to APRIL, heteromers consisting of one BAFF and two APRILs (BAA) bind to the receptors B cell maturation antigen (BCMA), transmembrane activator and CAML interactor (TACI) but not to the BAFF receptor (BAFFR). Heteromers consisting of one APRIL and two BAFF (ABB) bind to TACI and BCMA and weakly to BAFFR in accordance with the analysis of the receptor interaction sites in the crystallographic structure of ABB. Receptor binding correlated with activity in reporter cell line assays specific for BAFFR, TACI, or BCMA. Single-chain BAFF (BBB) and to a lesser extent single-chain ABB, but not APRIL or single-chain BAA, rescued BAFFR-dependent B cell maturation in BAFF-deficient mice. In conclusion, BAFF-APRIL heteromers of different stoichiometries have distinct receptor-binding properties and activities. Based on the observation that heteromers are less active than BAFF, we speculate that their physiological role might be to down-regulate BAFF activity.
Proc Natl Acad Sci U S A. 2024-7-16
J Cell Mol Med. 2025-2
Proc Natl Acad Sci U S A. 2024-7-16
Front Immunol. 2022
Saudi J Biol Sci. 2021-12
Front Cell Dev Biol. 2021-2-11
Front Cell Dev Biol. 2020-11-6
Expert Opin Ther Targets. 2014-4
Proc Natl Acad Sci U S A. 2013-11-18
J Biol Chem. 2012-9-7
Eur J Immunol. 2011-2-1
Acta Crystallogr D Biol Crystallogr. 2010-2